Skip to main content
LEXICON PHARMACEUTICALS, INC. logo

LEXICON PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · LXRX ISIN · US5288723027 US Manufacturing
Open in API
Filings indexed 1,032 across all filing types
Latest filing 2026-05-07 Report Publication Anno…
Country US United States of America
Listing US LXRX

About LEXICON PHARMACEUTICALS, INC.

https://www.lexpharma.com/

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines. The company utilizes a unique approach centered on gene science and genetics to identify and validate novel drug targets. Its mission is to pioneer precise treatments that transform the lives of patients with serious and chronic conditions. Lexicon's activities encompass the full spectrum of drug development, from initial research through to bringing approved therapies to market.

Recent filings

Filing Released Lang Actions
8-K - LEXICON PHARMACEUTICALS, INC. (0001062822) (Filer)
Report Publication Announcement Classification · 95% confidence The document is a Form 8-K current report under the Securities Exchange Act, primarily stating that the company issued a press release with its quarterly financial results and that the press release is attached as Exhibit 99.1. It does not contain the actual financial data but rather announces the release/publication of that report. Under the “menu vs meal” rule, this is an announcement of the report’s publication. Therefore, it is classified as a Report Publication Announcement (RPA).
2026-05-07 English
8-K - LEXICON PHARMACEUTICALS, INC. (0001062822) (Filer)
Capital/Financing Update Classification · 90% confidence The document is a Form 8-K “Current Report” announcing Lexicon’s entry into a $100 million Hercules Term Loan facility and related warrant issuance—as well as the creation of a direct financial obligation (loan), unregistered equity sales, and related covenants. This is neither an earnings release, annual or interim report, proxy, nor management discussion, but rather an update on the company’s financing activity. Therefore, it falls under Capital/Financing Update (CAP).
2026-05-06 English
4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Filer)
Director's Dealing
2026-03-03 English
4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Filer)
Director's Dealing
2026-03-03 English
4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Filer)
Director's Dealing
2026-03-03 English
4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Filer)
Director's Dealing
2026-03-03 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.